Brought to you by 
Genetica and Mitotix form research collaboration
13 Jul 1999
Executive Summary
Mitotix exclusively licensed retroviral technology from Genetica (genetic manipulation of mammalian cells) to identify and validate genes in support of new anti-cancer small-molecule and biotherapeutic drug discovery efforts begun at Mitotix in 1998.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genetica and Mitotix form research collaboration
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice